BioTech Medics, Inc.

OTC: BMCS · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Southlake, TX · TarrantCIK 0001384066Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 43

v0.1 · 5/100 weight · pillars only

↑ listing tenure, Altman-Z · ↓ market scale, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-10-16

Market cap

$41.1k

as of 2026-10-16

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is BioTech Medics, Inc.’s financial profile?

BioTech Medics, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Parallel Industries Inc.——Hemp Naturals, Inc.——IMV Inc.——Itoco Inc.——Regenicin, Inc.——Binovi Technologies Corp.——

Neighbors

Tarrant →

The Charles Schwab Corporation$23.9B74B D.R. Horton, Inc.$34.3B78B+TPG Inc.$2.4B57C Range Resources Corporation$3.0B83B+FirstCash Holdings, Inc$1.7B82B+American Airlines Group Inc.$54.6B65B

Key facts

CEOAnthony Keith Miller

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersSouthlake, TX

ExchangeOTC: BMCS

Employees—

IPO date2010-07-23

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.